Skip to content

[(2R,4R,5R)-4-cyano-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-methyloxolan-2-yl]methoxy-N-[(2S)-1-(2,2-dimethylpropoxy)-1-oxopropan-2-yl]phosphonamidic acid

C19H29N4O9P — CID 130281351

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC[(2R,4R,5R)-4-cyano-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-methyloxolan-2-yl]methoxy-N-[(2S)-1-(2,2-dimethylpropoxy)-1-oxopropan-2-yl]phosphonamidic acid
SMILESC[C@H](NP(=O)(O)OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(C#N)C1O)C(=O)OCC(C)(C)C
InChIInChI=1S/C19H29N4O9P/c1-11(15(26)30-10-18(2,3)4)22-33(28,29)31-8-12-14(25)19(5,9-20)16(32-12)23-7-6-13(24)21-17(23)27/h6-7,11-12,14,16,25H,8,10H2,1-5H3,(H,21,24,27)(H2,22,28,29)/t11-,12+,14?,16+,19+/m0/s1
InChIKeyMDZKSJFEPARZLP-ADHUVUIZSA-N
MW488.43 g/mol
LogP0.01
Rot. Bonds8

About [(2R,4R,5R)-4-cyano-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-methyloxolan-2-yl]methoxy-N-[(2S)-1-(2,2-dimethylpropoxy)-1-oxopropan-2-yl]phosphonamidic acid

[(2R,4R,5R)-4-cyano-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-methyloxolan-2-yl]methoxy-N-[(2S)-1-(2,2-dimethylpropoxy)-1-oxopropan-2-yl]phosphonamidic acid (PubChem CID 130281351) has the molecular formula C19H29N4O9P and a molecular weight of 488.43 g/mol. Its IUPAC name is [(2R,4R,5R)-4-cyano-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-methyloxolan-2-yl]methoxy-N-[(2S)-1-(2,2-dimethylpropoxy)-1-oxopropan-2-yl]phosphonamidic acid.

Molecular Properties

Compound Name[(2R,4R,5R)-4-cyano-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-methyloxolan-2-yl]methoxy-N-[(2S)-1-(2,2-dimethylpropoxy)-1-oxopropan-2-yl]phosphonamidic acid
PubChem CID130281351
Molecular FormulaC19H29N4O9P
Molecular Weight488.43 g/mol
Exact Mass488.17
IUPAC Name[(2R,4R,5R)-4-cyano-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-methyloxolan-2-yl]methoxy-N-[(2S)-1-(2,2-dimethylpropoxy)-1-oxopropan-2-yl]phosphonamidic acid
SMILESC[C@H](NP(=O)(O)OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(C#N)C1O)C(=O)OCC(C)(C)C
InChIInChI=1S/C19H29N4O9P/c1-11(15(26)30-10-18(2,3)4)22-33(28,29)31-8-12-14(25)19(5,9-20)16(32-12)23-7-6-13(24)21-17(23)27/h6-7,11-12,14,16,25H,8,10H2,1-5H3,(H,21,24,27)(H2,22,28,29)/t11-,12+,14?,16+,19+/m0/s1
InChIKeyMDZKSJFEPARZLP-ADHUVUIZSA-N
XLogP0.01
TPSA192.97 Ų
H-Bond Donors4
H-Bond Acceptors10
Rotatable Bonds8
Heavy Atoms33
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500488.43
LogP ≤ 50.01
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze [(2R,4R,5R)-4-cyano-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-methyloxolan-2-yl]methoxy-N-[(2S)-1-(2,2-dimethylpropoxy)-1-oxopropan-2-yl]phosphonamidic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [(2R,4R,5R)-4-cyano-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-methyloxolan-2-yl]methoxy-N-[(2S)-1-(2,2-dimethylpropoxy)-1-oxopropan-2-yl]phosphonamidic acid?
The IUPAC name of [(2R,4R,5R)-4-cyano-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-methyloxolan-2-yl]methoxy-N-[(2S)-1-(2,2-dimethylpropoxy)-1-oxopropan-2-yl]phosphonamidic acid (CID 130281351) is [(2R,4R,5R)-4-cyano-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-methyloxolan-2-yl]methoxy-N-[(2S)-1-(2,2-dimethylpropoxy)-1-oxopropan-2-yl]phosphonamidic acid.
What is the SMILES notation for [(2R,4R,5R)-4-cyano-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-methyloxolan-2-yl]methoxy-N-[(2S)-1-(2,2-dimethylpropoxy)-1-oxopropan-2-yl]phosphonamidic acid?
The canonical SMILES for [(2R,4R,5R)-4-cyano-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-methyloxolan-2-yl]methoxy-N-[(2S)-1-(2,2-dimethylpropoxy)-1-oxopropan-2-yl]phosphonamidic acid is C[C@H](NP(=O)(O)OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(C#N)C1O)C(=O)OCC(C)(C)C.
What is the InChIKey of [(2R,4R,5R)-4-cyano-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-methyloxolan-2-yl]methoxy-N-[(2S)-1-(2,2-dimethylpropoxy)-1-oxopropan-2-yl]phosphonamidic acid?
The InChIKey is MDZKSJFEPARZLP-ADHUVUIZSA-N. The full InChI is InChI=1S/C19H29N4O9P/c1-11(15(26)30-10-18(2,3)4)22-33(28,29)31-8-12-14(25)19(5,9-20)16(32-12)23-7-6-13(24)21-17(23)27/h6-7,11-12,14,16,25H,8,10H2,1-5H3,(H,21,24,27)(H2,22,28,29)/t11-,12+,14?,16+,19+/m0/s1.
What are the key properties of [(2R,4R,5R)-4-cyano-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-methyloxolan-2-yl]methoxy-N-[(2S)-1-(2,2-dimethylpropoxy)-1-oxopropan-2-yl]phosphonamidic acid?
[(2R,4R,5R)-4-cyano-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-methyloxolan-2-yl]methoxy-N-[(2S)-1-(2,2-dimethylpropoxy)-1-oxopropan-2-yl]phosphonamidic acid has a molecular weight of 488.43 g/mol, XLogP of 0.01, 8 rotatable bonds, 4 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,4R,5R)-4-cyano-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-methyloxolan-2-yl]methoxy-N-[(2S)-1-(2,2-dimethylpropoxy)-1-oxopropan-2-yl]phosphonamidic acid is sourced from PubChem (CID 130281351), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.